Wagner, Judith N. http://orcid.org/0000-0002-0776-6821
Leibetseder, Annette
Troescher, Anna
Panholzer, Juergen
von Oertzen, Tim J.
Funding for this research was provided by:
Johannes Kepler University Linz
Article History
Received: 10 December 2020
Revised: 20 February 2021
Accepted: 23 February 2021
First Online: 6 March 2021
Declarations
:
: JW reports personal fees from Boehringer Ingelheim, personal fees from UCB, outside the submitted work. AL reports grants from Roche GmbH, outside the submitted work. Dr. von Oertzen reports grants, personal fees and non-financial support from Novartis Pharma, personal fees from Roche Pharma, personal fees from Biogen Idec Austria, personal fees from Liva Nova, grants from Grossegger and Drbal GmbH, grants from Merck, personal fees from Indivior Austria GmbH, personal fees and non-financial support from gtec GmbH Austria, personal fees and non-financial support from Boehringer-Ingelheim, personal fees from Philips, personal fees and non-financial support from UCB Pharma, personal fees from Almirall, personal fees from Eisai, outside the submitted work; and he is webeditor in chief of the European Academy of Neurology (EAN), co-chair of the EAN scientific panel for epilepsy, and vice president of the Österreichische Gesellschaft für Epileptologie (Austrian ILAE chapter). JP and AT report no disclosures.
: Ethics approval was waived by the Ethics Committee of Upper Austria. The manuscript does not contain clinical studies or patient data.
: All data are included in the manuscript.